Nanjing Heron Pharmaceutical

Nanjing Heron Pharmaceutical is a China-based specialty pharmaceutical company focused on the research, development, and commercialization of innovative small molecule drugs and high-end complex generics. The company has established a leading expertise in Vitamin D analogs and topical drug delivery systems, targeting therapeutic areas such as bone metabolism, dermatology, and nephrology. Heron has successfully launched several products in the Chinese market, including Eldecalcitol and Calcipotriol, and maintains a robust pipeline of new chemical entities and improved formulations. Their business model integrates a comprehensive R&D center with GMP-certified manufacturing facilities to provide specialized treatments for chronic and complex diseases. The company is publicly traded on the National Equities Exchange and Quotations (NEEQ) in China.